K-ras mutations and anti-EGFr antibody therapy field

摘要

The present application relates to K-ras mutations, to polynucleotides encoding mutant K-ras polypeptides, and to methods of identifying K-ras mutations. The present application also relates to methods of diagnosing cancer; and methods and kits for predicting usefulness of anti-EGFr specific binding agents in the treatment of tumors.